Patent & IP news archive

Merz Pharmaceuticals LLC
v. Par Pharmaceutical Inc. et. al.

Complaint for False Marking
Civil Action No. 1:12-cv-01723-UNA; no judge yet assigned.
Filed on Dec. 17, 2012 in the U.S. District Court for the District of Delaware;

Plaintiffs

v.
Merz Pharmaceuticals
Morris, Nichols, Arsht & Tunnell LLP; Wilmington, DE
Jack B. Blumenfeld
Maryellen Noreika

Patents in case

  • 7,816,396: “Method for increasing the bioavailability of glycopyrrolate” by Roberts et. al. Prosecuted by Leydig, Voit & Mayer, Ltd.. Includes 8 claims (2 indep.). Was application 12/648,068. Granted 10/19/2010.
  • 7,638,552: “Method for increasing the bioavailability of glycopyrrolate” by Roberts et. al. Prosecuted by Leydig, Voit & Mayer, Ltd.. Includes 7 claims (1 indep.). Was application 12/325,755. Granted 12/29/2009.

Attorney? Our daily litigation alerts are free, awesome, and include complaint PDFs.

Case documents (PDF)

Litigant weblinks

Some content © 2007–2014 RPX Corporation.
Terms of service
Privacy policy
For DMCA requests contact help@priorsmart.com.